Hingge Hsu is listed as a director on 1 SEC Form D filing by 1 issuer in Jan 2011: NEXTWAVE PHARMACEUTICALS Inc (Cupertino, CA — pharmaceuticals — 2011; $27.2M reported sold to 11 investors).
What this means One deal on file with the SEC, filed Jan 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Anand Mehra (1 shared filing), Craig Chambliss (1 shared filing), DAYTON MISFELDT (1 shared filing), Frank Kung (1 shared filing), Gaurav Aggarwal (1 shared filing) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Hingge. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Hingge Hsu and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Hingge Hsu" (MA) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.